Drug Shortage Report for APO-NAPROXEN

Last updated on 2020-10-05 History
Report ID 121909
Drug Identification Number 00592277
Brand name APO-NAPROXEN
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-03
Estimated end date 2020-10-09
Actual end date 2020-10-02
Shortage status Resolved
Updated date 2020-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-10-05 French Compare
v5 2020-10-05 English Compare
v4 2020-09-09 French Compare
v3 2020-09-09 English Compare
v2 2020-08-06 French Compare
v1 2020-08-06 English Compare

Showing 1 to 6 of 6